Acceleron to Participate in Two Healthcare Investor Conferences in February
February 01 2017 - 7:00AM
Business Wire
Acceleron Pharma Inc. (NASDAQ: XLRN), a clinical stage
biopharmaceutical company focused on the discovery, development and
commercialization of innovative therapeutics to treat serious and
rare diseases, today announced that senior management will
participate in two upcoming healthcare investor conferences in
February.
Conference Details:
Event: LEERINK Partners 6th Annual Global
Healthcare Conference Date/Time: February 16, 2017 at 1:00 p.m. EST
Location: New York, NY Event: Jefferies’ Celgene
Collaborators Summit Date/Time: February 21, 2017 Location: New
York, NY
A live audio webcast for the LEERINK Partners Global Healthcare
Conference will be available on the Investors page of the Company's
website at www.acceleronpharma.com. A replay of the webcast will be
available approximately two hours after the event on the Acceleron
website.
About Acceleron
Acceleron is a clinical stage biopharmaceutical company focused
on the discovery, development and commercialization of innovative
therapeutics to treat serious and rare diseases. Its pioneering
research platform leverages the powerful biology behind the body’s
ability to rebuild and repair its own cells and tissues. This
approach to drug discovery has generated four therapeutic
candidates that are currently in clinical trials. The Company’s
lead therapeutic candidate, luspatercept, is being evaluated in
Phase 3 studies for the treatment of the hematologic diseases,
myelodysplastic syndromes (MDS) and beta-thalassemia under a global
partnership with Celgene Corp. Acceleron is also advancing clinical
programs in the fields of oncology and neuromuscular diseases and
has a comprehensive preclinical research effort targeting fibrotic
and other serious diseases.
For more information, please visit www.acceleronpharma.com.
Follow Acceleron on Social
Media: @AcceleronPharma and LinkedIn.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170201005134/en/
Acceleron Pharma Inc.Todd James, IRC, 617-649-9393Senior
Director, Investor Relations and Corporate
CommunicationsorMedia:BMC CommunicationsBrad Miles,
646-513-3125
Acceleron Pharma (NASDAQ:XLRN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acceleron Pharma (NASDAQ:XLRN)
Historical Stock Chart
From Apr 2023 to Apr 2024